Perceptions on the Future of Bispecific Therapies for NHL

Opinion
Video

Panelists discuss their perceptions of the future for patients treated with bispecific antibodies for non-Hodgkin lymphoma, highlighting key unmet needs and sharing clinical pearls for community oncologists.

Video content above is prompted by the following:

  1. What do you perceive the future to look like for patients being treated with bispecific antibodies for non-Hodgkin lymphoma?
  • What remain the key unmet needs?

Do you have any clinical pearls for the community oncologist?

Recent Videos
Related Content